Slit同源物2(Slit2)重組蛋白
Recombinant Slit Homolog 2 (Slit2)
SLIL3
- 編號RPA672Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量20.1kDa
- 實際分子量24kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Val1160~Cys1333 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.5
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
econstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA672Hu03 | Slit同源物2(Slit2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA672Hu01 | Slit同源物2(Slit2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA672Hu02 | Slit同源物2(Slit2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA672Hu01 | Slit同源物2(Slit2)多克隆抗體 | WB; IHC; ICC; IP. |
PAA672Hu02 | Slit同源物2(Slit2)多克隆抗體 | WB; IHC; ICC; IP. |
PAA672Hu03 | Slit同源物2(Slit2)多克隆抗體 | WB; IHC; ICC; IP. |
LAA672Hu71 | Slit同源物2(Slit2)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA672Hu22 | Slit同源物2(Slit2)單克隆抗體 | WB; IHC; ICC; IP. |
SEA672Hu | Slit同源物2(Slit2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA672Hu | Slit同源物2(Slit2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Cancer Research | SLIT2 Attenuation during Lung Cancer Progression Deregulates β-Catenin and E-Cadherin and Associates with Poor Prognosis [AACR: 702543] |
Carcinogenesis | Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line [OxfordJournals: source] |
PLoS?One | Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation [Pubmed:26889680] |
ESC Heart Fail | Crosstalk between the activated Slit2¨CRobo1 pathway and TGF?\|?1 signalling promotes cardiac fibrosis [33236535] |
留言咨詢